Fecal metabolomics in pediatric spondyloarthritis implicate decreased metabolic diversity and altered tryptophan metabolism as pathogenic factors

Genes and Immunity

Volumn 17, Issue 7, 2016, Pages 400-405

  Stoll, M L ^a   Kumar, R ^b   Lefkowitz, E J ^c   Cron, R Q ^a   Morrow, C D ^d   Barnes, S ^e  

^a University of Alabama at Birmingham and Children's Hospital   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e The Purdue Univ Univ of Alabama at Birmingham Botanical Center for Age Related Disease   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHAN; DNA 16S; TRYPTOPHAN; RNA 16S; VIRULENCE FACTOR;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENTHESITIS; ENTHESITIS RELATED ARTHRITIS; FECES; FECES ANALYSIS; FEMALE; HUMAN; INTESTINE FLORA; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; METABOLOMICS; MICROBIAL GENE; PRIORITY JOURNAL; PURINE METABOLISM; SPONDYLARTHRITIS; TRYPTOPHAN METABOLISM; JUVENILE RHEUMATOID ARTHRITIS; METABOLISM;

ADOLESCENT; ARTHRITIS, JUVENILE; CHILD; COHORT STUDIES; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; MALE; METABOLOMICS; RNA, RIBOSOMAL, 16S; SPONDYLARTHRITIS; TRYPTOPHAN; VIRULENCE FACTORS;

EID: 84992345014     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2016.38     Document Type: Article

References (38)

1. Stoll ML. Gut microbes, immunity, and spondyloarthritis. Clin Immunol 2015; 159: 134-142.
2. Stoll ML, Kumar R, Morrow CD, Lefkowitz EJ, Cui X, Genin A et al. Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis. Arthritis Res Ther 2014; 16: 486.
3. Stebbings S, Munro K, Simon MA, Tannock G, Highton J, Harmsen H et al. Comparison of the faecal microflora of patients with ankylosing spondylitis and controls using molecular methods of analysis. Rheumatology (Oxford) 2002; 41: 1395-1401.
4. Costello ME, Ciccia F, Willner D, Warrington N, Robinson PC, Gardiner B et al. Intestinal dysbiosis in ankylosing spondylitis. Arthritis Rheumatol 2015; 67: 686-691.
5. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464: 59-65.
6. Macarulla MT, Alberdi G, Gomez S, Tueros I, Bald C, Rodriguez VM et al. Effects of different doses of resveratrol on body fat and serum parameters in rats fed a hypercaloric diet. J Physiol Biochem 2009; 65: 369-376.
7. Bjerrum JT, Wang Y, Hao F, Coskun M, Ludwig C, Gunther U et al. Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals. Metabolomics 2015; 11: 122-133.
8. Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F et al. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res 2007; 6: 546-551.
9. Shiomi Y, Nishiumi S, Ooi M, Hatano N, Shinohara M, Yoshie T et al. GCMS-based metabolomic study in mice with colitis induced by dextran sulfate sodium. Inflamm Bowel Dis 2011; 17: 2261-2274.
10. Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res 2016; 44: D457-D462.
11. Ma H, Sorokin A, Mazein A, Selkov A, Selkov E, Demin O et al. The Edinburgh human metabolic network reconstruction and its functional analysis. Mol Syst Biol 2007; 3: 135.
12. Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 2013; 31: 814-821.
13. Kageyama G, Saegusa J, Irino Y, Tanaka S, Tsuda K, Takahashi S et al. Metabolomics analysis of saliva from patients with primary Sjogren's syndrome. Clin Exp Immunol 2015; 182: 149-153.
14. Scher JU, Ubeda C, Artacho A, Attur M, Isaac S, Reddy SM et al. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol 2015; 67: 128-139.
15. Michail S, Durbin M, Turner D, Griffiths AM, Mack DR, Hyams J et al. Alterations in the gut microbiome of children with severe ulcerative colitis. Inflamm Bowel Dis 2012; 18: 1799-1808.
16. Kang KY, Lee SH, Jung SM, Park SH, Jung BH, Ju JH. Downregulation of tryptophan-related metabolomic profile in rheumatoid arthritis synovial fluid. J Rheumatol 2015; 42: 2003-2011.
17. Lamas B, Richard ML, Leducq V, Pham HP, Michel ML, Da Costa G et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat Med 2016; 22: 598-605.
18. Arvonen M, Berntson L, Pokka T, Karttunen TJ, Vahasalo P, Stoll ML. Gut microbiota-host interactions and juvenile idiopathic arthritis. Pediatr Rheumatol Online J 2016; 14: 44.
19. Zheng X, Xie G, Zhao A, Zhao L, Yao C, Chiu NH et al. The footprints of gut microbial-mammalian co-metabolism. J Proteome Res 2011; 10: 5512-5522.
20. Stoll ML, Cron RQ. The microbiota in pediatric rheumatic disease: epiphenomenon or therapeutic target. Curr Opin Rheumatol 2016; 28: 537-543.
21. Oxenkrug GF. Tryptophan kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: the serotonin hypothesis revisited 40 years later. Isr J Psychiatry Relat Sci 2010; 47: 56-63.
22. Cribbs AP, Kennedy A, Penn H, Read JE, Amjadi P, Green P et al. Treg cell function in rheumatoid arthritis is compromised by ctla-4 promoter methylation resulting in a failure to activate the indoleamine 2, 3-dioxygenase pathway. Arthritis Rheumatol 2014; 66: 2344-2354.
23. Sridharan GV, Choi K, Klemashevich C, Wu C, Prabakaran D, Pan LB et al. Prediction and quantification of bioactive microbiota metabolites in the mouse gut. Nat Commun 2014; 5: 5492.
24. Hubbard TD, Murray IA, Perdew GH. Indole and tryptophan metabolism: endogenous and dietary routes to Ah receptor activation. Drug Metab Dispos 2015; 43: 1522-1535.
25. Esser C, Rannug A, Stockinger B. The aryl hydrocarbon receptor in immunity. Trends Immunol 2009; 30: 447-454.
26. Lahoti TS, John K, Hughes JM, Kusnadi A, Murray IA, Krishnegowda G et al. Aryl hydrocarbon receptor antagonism mitigates cytokine-mediated inflammatory signalling in primary human fibroblast-like synoviocytes. Ann Rheum Dis 2013; 72: 1708-1716.
27. Mohinta S, Kannan AK, Gowda K, Amin SG, Perdew GH, August A. Differential regulation of Th17 and T regulatory cell differentiation by aryl hydrocarbon receptor dependent xenobiotic response element dependent and independent pathways. Toxicol Sci 2015; 145: 233-243.
28. Yang TH, Hsu PY, Meng M, Su CC. Supplement of 5-hydroxytryptophan before induction suppresses inflammation and collagen-induced arthritis. Arthritis Res Ther 2015; 17: 364.
29. Hubbard TD, Murray IA, Bisson WH, Lahoti TS, Gowda K, Amin SG et al. Adaptation of the human aryl hydrocarbon receptor to sense microbiota-derived indoles. Sci Rep 2015; 5: 12689.
30. Hatton RD, Weaver CT. Duality in the Th17-Treg developmental decision. F1000 Biol Rep 2009; 1: 5.
31. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 390-392.
32. Cary SG, Blair EB. New transport medium for shipment of clinical specimens. I. Fecal specimens. J Bacteriol 1964; 88: 96-98.
33. Wilson L, Arabshahi A, Simons B, Prasain JK, Barnes S. Improved high sensitivity analysis of polyphenols and their metabolites by nano-liquid chromatographymass spectrometry. Arch Biochem Biophys 2014; 559: 3-11.
34. Li S, Park Y, Duraisingham S, Strobel FH, Khan N, Soltow QA et al. Predicting network activity from high throughput metabolomics. PLoS Comput Biol 2013; 9: e1003123.
35. Li S, Pozhitkov A, Ryan RA, Manning CS, Brown-Peterson N, Brouwer M. Constructing a fish metabolic network model. Genome Biol 2010; 11: R115.
36. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010; 7: 335-336.
37. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 2010; 26: 2460-2461.
38. Lozupone C, Knight R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol 2005; 71: 8228-8235.